Boston Scientific Appoints Daniel J. Brennan Vice President of Investor Relations

NATICK, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that Daniel J. Brennan has been appointed to the position of Vice President Investor Relations. In this role, Dan will be responsible for all aspects of investor relations. Dan will report to Larry Best, Executive Vice President and Chief Financial Officer.

Dan comes to the position with over 10 years experience at Boston Scientific. He has served most recently as Vice President of International Finance. Previous positions include Vice President of Cardiovascular Finance (Maple Grove, MN) as well as Director of Finance for two separate operating units in the Boston Scientific Endosurgery Group.

"The goal for Dan in his new role will be to build an investor relations function at Boston Scientific that sets a new standard within the medical device industry," said Best. "In the months ahead, Dan will be reaching out to the various constituencies within the investment community to identify ways in which the company may best serve them."

Milan Kofol, who has served as head of Investor Relations in addition to overseeing Treasury, will continue in his role as the Company's Treasurer.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit:

This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, integration of acquired companies, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.

  CONTACT:  Paul Donovan
            508-650-8541 (office)
            508-667-5165 (mobile)
            Media Relations
            Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Paul Donovan of Boston Scientific, +1-508-650-8541, or mobile:
+1-508-667-5165 (mobile)

Web site: